Xeris Biopharma COO Kevin McCulloch sells $250,000 common shares
Kevin McCulloch sold 25,000 common shares at $10 on Sept. 28, 2026 under a Rule 10b5-1 plan, reducing his stake to 1,614,208 shares.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.